Floatz logo

Oxycodone

Opiate Addiction

Member Companies of the Opioid PMR ConsortiumSmall moleculePhase 4 / ApprovedDormant
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
53/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Opiate Addiction cohort.

Asset / SponsorPhaseRating
Buprenorphine
Erin Winstanley
Phase 4BBB
METHADONE
University of Maryland, Baltimore
Phase 4BBB
NEPENTHE
Lyndra Inc.
Phase 4BB
17-ALLYL-4,5A-EPOXY-3,14-DIHYDROXYMORPHINAN-6-ONE
University of California, San Francisco
Phase 4BB
OXYMORPHONE CII
Member Companies of the Opioid PMR Consortium
Phase 4B

Same molecule, other indications

Oxycodone is also rated in:

Low Back PainDormant
BBB
Indicative ·
77 / 100
View asset →
PainDormant
BBB
Indicative ·
74 / 100
View asset →
osteoarthritisDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →